A life-sciences R and D strategy allocates scarce R and D capital across a portfolio of programmes to maximise risk-adjusted value, using disciplined stage-gate governance. This is the Life Sciences R and D Strategy from the Stratenity Library, a governed consulting deliverable that is already built for you. It gives your team the full working method for life sciences r and d strategy, and it walks through everything from target and pipeline strategy to external innovation and partnerships. Every asset ships with a worked client example, a clear RACI, defined KPIs, and governance you can defend, so your team adapts it to a live client engagement instead of starting from a blank page.
What this asset covers
This is a preview of the full deliverable. Inside the Stratenity Library, this asset walks a consultant through the complete method, section by section, with a worked client example threaded throughout.
- The R and D Productivity Challenge
- Portfolio Strategy and Prioritisation
- Target and Pipeline Strategy
- Clinical Development Design
- The R and D Operating Model
- Data, AI, and Digital in R and D
- External Innovation and Partnerships
- Trial Operations and Speed
- Regulatory Strategy
- R and D Productivity Metrics
- Roadmap and Investment
- Applying R and D Strategy to a Real Company
- Common Pitfalls and the Deliverable Pack
Review, download, and activate in 48 hours
Stratenity Library subscribers can review this asset in full, download it, and activate it into a governed, client-ready deliverable in 48 hours rather than weeks. Each asset ships with a worked client example, a clear RACI, defined KPIs, and governance you can defend.
Read the full asset on the Stratenity Library › Not a member yet? Start a free trial to unlock and activate it, or sign in if you already have an account.